Global proliferative diabetic retinopathy (pdr) market size is expected at 3.62 Bn by 2028 at a growth rate of 10.6% and growth analysis by The Business Research Company.
Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease. Read more details at: http://www.bigmarketresearch.com/global-diabetic-retinopathy-2015-2019-market
The global diabetic socks market size was USD 344.80 Million in 2021 and is expected to register a revenue CAGR of 4.8% during the forecast period, according to latest analysis by Emergen Research. Increasing prevalence of diabetics and related complications such as Diabetic Food Ulcer (DFC) and diabetic neuropathy, growing consumer demand for better & improved accessibility and benefits offered by diabetic socks to patients over regular socks, and introduction of innovative smart sock technology are factors driving market revenue growth.
Download Sample Brochure @ http://bit.ly/2e9aeL8 DelveInsight’s Diabetic retinopathy - Market Insights, Epidemiology and Market Forecast-2020” Reports provides an overview of the disease and global market trends of the %Indication"% for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Diabetic retinopathy forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Diabetic retinopathy till 2020. Read Analysis @ http://bit.ly/2dRoh9m
The research team projects that the Diabetic Retinopathy Treatment market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The global diabetic retinopathy market accounted for over USD 6,810 million in 2017 and is expected to grow at a CAGR of 8.7% during the forecast period, 2019–2026.
According to the latest research report by IMARC Group, The global ophthalmic devices market size reached US$ 27.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032. More Info:- https://www.imarcgroup.com/ophthalmic-devices-market
The study segments the diabetic retinopathy industry in light of major classification such as product type, potential markets, application, and end-user.
Global Widefield Imaging Systems Market will exhibit a CAGR of around 7.35% for the forecast period of 2022-2028. Widefield imaging systems are used in diagnosing and detecting uveitis, diabetic retinopathy, retinal vascular tumours among others. Widefield imaging systems offer excellent postoperative documentation of retinal surgery. Widefield imaging systems is an imaging technology that relies on illumination with the resulting image being viewed and observed by an observer through the camera. The widefield imaging systems are rapidly being adopted by hospitals, clinics, and ambulatory surgery centres. Get Full Access of Report @ https://www.databridgemarketresearch.com/reports/global-widefield-imaging-systems-market
Diabetic macular edema treatment market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 3.65% in the above mentioned forecast period and would likely to reach an estimated value of 63.33 million by 2029 https://www.databridgemarketresearch.com/reports/global-diabetic-macular-edema-treatment-market
This report offers an analysis of the market based on product (reusable ophthalmic knives and single-use ophthalmic knives). The ophthalmic knives market research report further presents an in-depth insight on the growth prospects of the market across Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including Bausch Health, Diamatrix Ltd., HAI Laboratories, Inc., MANI, INC., Novartis AG, and Sidapharm.
This report offers an analysis of the market based on product (reusable ophthalmic knives and single-use ophthalmic knives). The ophthalmic knives market research report further presents an in-depth insight on the growth prospects of the market across Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including Bausch Health, Diamatrix Ltd., HAI Laboratories, Inc., MANI, INC., Novartis AG, and Sidapharm.
The growth of the injectable drug delivery technologies market is primarily triggered by favorable reimbursement policies on injectable drugs and devices, technological advancements, surge of biologics in pharmaceutical markets, rising incidences of cancer and diabetes in Europe, and improving patient compliance. See Full Report : http://bit.ly/1c4gocE
The physiotherapy equipment market is estimated to grow at a CAGR of 6.8%to reach $19,786.3 million by 2019.Electric stimulation is the largest segment of the market. However, musculoskeletal will be the fastest-growing application segment during the forecast period. See Full Report @ bit.ly/1uVqa9w
The global ocular drug delivery market size valued at $67.7 billion in 2022, and is projected to reach $115.5 billion by 2032, growing at a CAGR of 5.5% from 2023 to 2032. The ocular drug delivery market growth is driven by advancement in ocular drug delivery technology, surge in ageing population, and rise in awareness about the various eye disorders. Aged population increases susceptibility to conditions such as age-related macular degeneration (AMD), cataracts, glaucoma, and diabetic retinopathy. Know More- https://www.alliedmarketresearch.com/ocular-drug-delivery-market
Ocular Drug Delivery Technology Market report categorize the global market by Technology (Topical, Ocular Inserts, Iontophoresis, Intraocular Implants and In Situ Gel & Punctal Plugs), Disease Type (Glaucoma, Diabetic Retinopathy, Macular Degeneration), End User & Geography
Globally, the ophthalmic devices market is witnessing significant growth due to increasing prevalence of eye disorders, such as diabetic retinopathy and macular degeneration. In addition, growing global aging population, increasing government initiatives towards healthcare infrastructure in developing countries, and increasing incidence of lifestyle-associated diseases are also driving the growth of the market.
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors.
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors.
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan). Despite its enormous potential, the MCD market is facing the major global barrier in the sparsely populated pipeline. The diabetic retinopathy segment of the market has recently seen rapid uptake of novel anti-VEGF therapies and is experiencing a strong growth. On the other hand, the diabetic neuropathy and nephropathy segments face the barrier in and increasing number of generic competitors.
The rising incidences of colorectal cancer, chronic pain, cardiovascular diseases and diabetic retinopathy and unwanted pregnancies globally are expected to drive the implantable drug delivery devices market.
The entire market for microvascular complications of diabetes (MCD) – diabetic nephropathy, retinopathy, and neuropathy – is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan).
The entire market for microvascular complications of diabetes (MCD) diabetic nephropathy, retinopathy, and neuropathy is facing an extremely high level of unmet need across the 7MM (US, 5EU and Japan).
The MRI systems market report analyzes the MRI systems market, the major driving forces and potential challenges that could restrict growth which is driven by developing economies and also provides comprehensive information on the key analytical content on the dynamics of the market. Browse full report @ http://bit.ly/1M3T23c
The vascular endothelial growth factor (VEGF) inhibitor market size is expected to see strong growth in the next few years. It will grow to $13.98 billion in 2028 at a compound annual growth rate (CAGR) of 7.5%.
Vitrectomy serves as major treatment option that has gained popularity since the past few years and also offers retina correction for the entire field of the interior of the eye, which includes the peripheral vision. Moreover, when it comes to defining Vitrectomy, it is a surgical procedure employed to eradicate vitreous gel from the eye. This process is done when there is an occurrence of retinal detachment with vitreous haemorrhage. In addition, this procedure is used for eradication of scar tissue and treatment for small holes or tear in the macula.
According to the latest research report by IMARC Group, The global eye health supplements market size is projected to exhibit a growth rate (CAGR) of 5.4% during 2024-2032. More Info:- https://www.imarcgroup.com/eye-health-supplements-market
According to Prevent Blindness statistics, the prevalence of diabetic retinopathy in the U.S. is estimated to be 5.3%. VEGF-A antagonist is largely prescribed for the diabetic retinopathy treatment and also for treatment of diabetic macular edema.
Stay up-to-date with latest Insights of Ophthalmic Drugs Market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth. Get More Info@ https://www.alliedmarketresearch.com/ophthalmic-drugs-market
The ophthalmic devices refer to the type of devices that are utilized in the diagnosis and treatment of eyes associated diseases such as vision loss due to aging, glaucoma treatment, cataract surgeries, peripheral vitreoretinal disease, and refractive eye state, among others. The technological advancements across the globe acts as one of the major factors driving the growth of ophthalmic surgical instruments market. The increase in prevalence of eye disorders, such as glaucoma, cataract, and vitreoretinal disorders, and rise in preference for minimally invasive surgical options that provide permanent solutions to common ophthalmic conditions accelerate the market growth.
According to the latest research report by IMARC Group, The global vision care market size reached US$ 71.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 93.9 Billion by 2032, exhibiting a growth rate (CAGR) of 3% during 2024-2032. More Info:- https://www.imarcgroup.com/vision-care-market
According to our latest study on “Vitrectomy Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, Patient Type, Surgery Approach, End-User, and Distribution Channel,” the market is projected to reach US$ 2,003.24 million by 2028 from US$ 1,290.19 million in 2021; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028.
Global retinal disorder treatment market size is expected at $16.42 Bn by 2027, at a growth rate of 9.1% and growth analysis by The Business Research Company.
Ophthalmology is basically the branch of medical science study of the eye and its various structure, function and treatment, cure and diagnosis of eye diseases and clinical conditions, such as cataract, diabetic retinopathy, age-related macular degeneration, glaucoma and astigmatism. The ophthalmology devices are medical equipment designed for surgery, diagnosis and vision correction.
According to the latest study on “Vision Care Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, and Distribution Channel,” the market was valued at US$ 66,934.51 million in 2019 and is projected to reach US$ 93,817.82 million by 2027; it is expected to grow at a CAGR of 4.5% during 2020–2027. The report highlights the trends prevailing in the global vision care market, and drivers and deterrents pertaining to the market growth.
Retinal Surgery Device Market will be US$ 2.87 Billion by 2027. Global Forecast, Impact of COVID-19, Industry Trends, by Product, Application, Growth, Opportunity Company Analysis.
In 2017, sales of neuromodulation devices remained on the upside and a similar trend is likely to follow in 2018. Neuromodulation has gained significant traction over the past couple of years, which has reflected favourably on the Global Neuromodulation Devices Market.
In 2017, sales of neuromodulation devices remained on the upside and a similar trend is likely to follow in 2018. Neuromodulation has gained significant traction over the past couple of years, which has reflected favourably on the Global Neuromodulation Devices Market.
The prevalence of eye diseases such as glaucoma, cataracts, and so on is increasing significantly worldwide, as a consequence of increasing incidences of chronic disorders such as hypertension and diabetes. Due to changing lifestyle, the number of patients affected with diabetes and hypertension has increased considerably, thereby resulting in growth of ocular hypertension and diabetic retinopathy. The number of patients suffering from ophthalmic disorders is anticipated to increase in coming years and is in turn expected to accelerate the demand for ophthalmic devices.
The global ophthalmic equipment market size was USD 60.49 Billion in 2021 and is expected to register a revenue CAGR of 5.0% during the forecast period, according to latest analysis by Emergen Research. Rising prevalence of glaucoma, cataracts, and other ocular conditions, increasing need for Research & Development (R&D) due to prevalence of eye-related diseases, need for improved patient outcomes, and use of cutting-edge technologies are major factors driving market revenue growth.
iGATE Research has released a research report on “Global Retinal Surgery Devices Market (By Devices Segment, Application, Geography, Region and Company Profile) – Forecast to 2026” Click here to view the complete report: https://www.igateresearch.com/global-retinal-surgery-devices-market-by-devices-segment-application-geography-region-and-company-profile-forecast-to-2026.html Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
The ocular drug delivery market was valued at US$ 16,404.32 million in 2021 and is projected to reach US$ 27,016.20 million by 2028; it is expected to grow at a CAGR of 7.4 % from 2021 to 2028.
The global ophthalmic devices market was valued around $31 billion in 2017. USA was the largest market accounting for around 22% of the total market. Read More: https://www.thebusinessresearchcompany.com/report/ophthalmic-devices-market-global-briefing-2018
The major factors that drive the growth of the global ocular drug delivery technology market are the low bioavailability of drugs in conventional ocular therapies, increase in the incidence of glaucoma & macular degeneration, growing demand for targeted ocular drug delivery techniques, and increase in the number of approvals from government regulations for new ocular drug delivery techniques. Get sample copy of this report: https://goo.gl/S9nZMM